首页 > 最新文献

Gastroenterologia y hepatologia最新文献

英文 中文
Early advanced therapies and real-world outcomes in Crohn's disease: A population-based comparison of two incident cohorts in Navarra 克罗恩病的早期先进治疗和现实世界结果:纳瓦拉两个事件队列的基于人群的比较
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1016/j.gastrohep.2025.502540
Alfonso Elosua , Óscar Nantes , María Chaparro , Lucía Zabalza , Rebeca Irisarri , Miren Vicuña , Marcos Kutz , Saioa Rubio , Julián Librero , Ramón Angós , Ana Garre , Javier P. Gisbert , Cristina Rodríguez

Objective

The introduction of biologic therapies has transformed the management of Crohn's disease (CD), yet few studies have evaluated their impact on real-world outcomes over time. We aimed to compare two population-based cohorts of CD patients in Navarra, Spain, diagnosed in 2001–2003 (cohort A) and in 2017 (cohort B), to assess whether early use of advanced therapies has altered disease trajectory.

Patients and methods

This prospective, multicentre cohort study included adult patients with confirmed CD from two periods. Clinical characteristics, treatments, hospitalizations, and surgical outcomes were analysed over five years. Time-to-event analyses were performed using Kaplan–Meier curves and Cox regression models.

Results

A total of 128 patients were included (83 in cohort A, 45 in cohort B). At diagnosis, immunomodulators were used in 1.2% of cohort A vs. 21% in cohort B, and biologics in 0% vs. 51%, respectively. Initiation of immunomodulators (hazard ratio [HR]: 1.94; 95% CI: 1.11–3.39) and biologics (HR: 5.42; 95% CI: 2.57–11.42) occurred earlier in cohort B. Hospitalization at diagnosis was more frequent in cohort A (47% vs. 22%), and five-year hospitalization rates were significantly lower in cohort B (34% vs. 63%; HR: 0.52; 95% CI: 0.28–0.96). No significant differences in intestinal or perianal surgery rates were observed between cohorts.

Conclusions

Earlier and more widespread use of advanced therapies in CD has been associated with reduced hospitalization over time, although surgical rates have remained stable. These findings suggest a shift toward earlier and more intensive treatment strategies in routine clinical practice.
目的:生物疗法的引入已经改变了克罗恩病(CD)的治疗方式,但很少有研究评估它们对现实世界结果的影响。我们旨在比较2001-2003年诊断的西班牙纳瓦拉(Navarra)的两个基于人群的CD患者队列(队列A)和2017年诊断的CD患者队列(队列B),以评估早期使用先进疗法是否改变了疾病轨迹。患者和方法:这项前瞻性、多中心队列研究包括两个时期确诊的成年CD患者。临床特点,治疗,住院和手术结果分析超过五年。使用Kaplan-Meier曲线和Cox回归模型进行时间-事件分析。结果:共纳入128例患者(A队列83例,B队列45例)。在诊断时,免疫调节剂在队列A中占1.2%,在队列B中占21%,生物制剂在队列B中占0%,在队列B中占51%。免疫调节剂(风险比[HR]: 1.94; 95% CI: 1.11-3.39)和生物制剂(风险比:5.42;95% CI: 2.57-11.42)在队列B中较早开始使用。在队列A中诊断时住院的频率更高(47%对22%),队列B的5年住院率显著较低(34%对63%;风险比:0.52;95% CI: 0.28-0.96)。肠道或肛周手术率在队列间无显著差异。结论:尽管手术率保持稳定,但随着时间的推移,更早和更广泛地使用先进的治疗方法与减少住院率有关。这些发现表明,在常规临床实践中,应转向更早、更强化的治疗策略。
{"title":"Early advanced therapies and real-world outcomes in Crohn's disease: A population-based comparison of two incident cohorts in Navarra","authors":"Alfonso Elosua ,&nbsp;Óscar Nantes ,&nbsp;María Chaparro ,&nbsp;Lucía Zabalza ,&nbsp;Rebeca Irisarri ,&nbsp;Miren Vicuña ,&nbsp;Marcos Kutz ,&nbsp;Saioa Rubio ,&nbsp;Julián Librero ,&nbsp;Ramón Angós ,&nbsp;Ana Garre ,&nbsp;Javier P. Gisbert ,&nbsp;Cristina Rodríguez","doi":"10.1016/j.gastrohep.2025.502540","DOIUrl":"10.1016/j.gastrohep.2025.502540","url":null,"abstract":"<div><h3>Objective</h3><div>The introduction of biologic therapies has transformed the management of Crohn's disease (CD), yet few studies have evaluated their impact on real-world outcomes over time. We aimed to compare two population-based cohorts of CD patients in Navarra, Spain, diagnosed in 2001–2003 (cohort A) and in 2017 (cohort B), to assess whether early use of advanced therapies has altered disease trajectory.</div></div><div><h3>Patients and methods</h3><div>This prospective, multicentre cohort study included adult patients with confirmed CD from two periods. Clinical characteristics, treatments, hospitalizations, and surgical outcomes were analysed over five years. Time-to-event analyses were performed using Kaplan–Meier curves and Cox regression models.</div></div><div><h3>Results</h3><div>A total of 128 patients were included (83 in cohort A, 45 in cohort B). At diagnosis, immunomodulators were used in 1.2% of cohort A vs. 21% in cohort B, and biologics in 0% vs. 51%, respectively. Initiation of immunomodulators (hazard ratio [HR]: 1.94; 95% CI: 1.11–3.39) and biologics (HR: 5.42; 95% CI: 2.57–11.42) occurred earlier in cohort B. Hospitalization at diagnosis was more frequent in cohort A (47% vs. 22%), and five-year hospitalization rates were significantly lower in cohort B (34% vs. 63%; HR: 0.52; 95% CI: 0.28–0.96). No significant differences in intestinal or perianal surgery rates were observed between cohorts.</div></div><div><h3>Conclusions</h3><div>Earlier and more widespread use of advanced therapies in CD has been associated with reduced hospitalization over time, although surgical rates have remained stable. These findings suggest a shift toward earlier and more intensive treatment strategies in routine clinical practice.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"49 2","pages":"Article 502540"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Banding-and-SINK for small (≤10-mm) gastrointestinal subepithelial tumours: A valid and effective alternative 小的(≤10mm)胃肠道上皮下肿瘤的捆扎- sink:一种有效的替代方法。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1016/j.gastrohep.2025.502539
Joan B. Gornals , Sandra Maisterra , Francesc Bas-Cutrina
{"title":"Banding-and-SINK for small (≤10-mm) gastrointestinal subepithelial tumours: A valid and effective alternative","authors":"Joan B. Gornals ,&nbsp;Sandra Maisterra ,&nbsp;Francesc Bas-Cutrina","doi":"10.1016/j.gastrohep.2025.502539","DOIUrl":"10.1016/j.gastrohep.2025.502539","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"49 2","pages":"Article 502539"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatiga en pacientes con enfermedad inflamatoria intestinal: estudio descriptivo transversal 炎症性肠病患者的疲劳:一项描述性横断面研究。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1016/j.gastrohep.2025.502557
Ana M. López-Calleja , Beatriz López-Cauce , Marisa Iborra Colomino , Beatriz Villarrubia-Martín , Luis Menchén , Carmen Lobo-Rodríguez

Aim

To identify factors associated with the presence of fatigue in patients with inflammatory bowel disease.

Patients and method

Prospective cross-sectional descriptive study conducted in a multidisciplinary centre for the treatment of immune-mediated inflammatory disease (IMID). Participants were patients diagnosed with inflammatory bowel diseases (IBD) under follow-up in an advanced practice nurse (APN) consultation. Sociodemographic and clinical variables, biochemical parameters, disease activity, quality of life, severity of fatigue, anxiety and depression were collected. A multivariate analysis was performed with logistic regression adjusted for sex and years of disease progression.

Results

A total of 243 patients were included, 174 (71.6%) with Crohn's disease and 69 (28.4%) with ulcerative colitis; 73 (30.2%) reported fatigue. Patients with fatigue had a significantly lower quality of life EuroQol-5D-5L: 60.08 vs. 76.34, (P < .001, 95% CI: 12.15-20.36) and IBDQ-9 57.53 vs. 76.54 (P < .001, 95% CI: 15.35-22.67). The regression model adjusted for sex and years of disease included moderate disease activity (OR: 4.88, P < .001, 95% CI: 2.13-11. 14), probable case of anxiety (OR: 2.16, P = .031, 95% CI: 0.78-4.34), probable case of depression (OR: 2.86, P = .004, 95% CI: 1.41-5.81).

Conclusions

Fatigue was significantly associated with poorer health-related quality of life in patients with moderate disease activity and those experiencing anxiety or depression. These findings highlight the necessity of a comprehensive approach that includes early detection of fatigue and associated psychosocial factors.
目的:确定炎症性肠病患者出现疲劳的相关因素。患者和方法:在一个多学科中心进行的EIMI治疗的前瞻性横断面描述性研究。参与者是在高级执业护士(APN)咨询中被诊断为IBD的患者。收集社会人口学和临床变量、生化参数、疾病活动性、生活质量、疲劳严重程度、焦虑和抑郁。对性别和疾病进展年数进行了调整后的logistic回归进行了多变量分析。结果:共纳入243例患者,其中克罗恩病174例(71.6%),溃疡性结肠炎69例(28.4%);73例(30.2%)报告疲劳。疲劳患者的生活质量显著降低,EuroQol-5D-5L: 60.08 vs. 76.34。结论:在中度疾病活动度和焦虑或抑郁患者中,疲劳与较差的健康相关生活质量显著相关。这些发现强调了一种综合方法的必要性,包括早期发现疲劳和相关的社会心理因素。
{"title":"Fatiga en pacientes con enfermedad inflamatoria intestinal: estudio descriptivo transversal","authors":"Ana M. López-Calleja ,&nbsp;Beatriz López-Cauce ,&nbsp;Marisa Iborra Colomino ,&nbsp;Beatriz Villarrubia-Martín ,&nbsp;Luis Menchén ,&nbsp;Carmen Lobo-Rodríguez","doi":"10.1016/j.gastrohep.2025.502557","DOIUrl":"10.1016/j.gastrohep.2025.502557","url":null,"abstract":"<div><h3>Aim</h3><div>To identify factors associated with the presence of fatigue in patients with inflammatory bowel disease.</div></div><div><h3>Patients and method</h3><div>Prospective cross-sectional descriptive study conducted in a multidisciplinary centre for the treatment of immune-mediated inflammatory disease (IMID). Participants were patients diagnosed with inflammatory bowel diseases (IBD) under follow-up in an advanced practice nurse (APN) consultation. Sociodemographic and clinical variables, biochemical parameters, disease activity, quality of life, severity of fatigue, anxiety and depression were collected. A multivariate analysis was performed with logistic regression adjusted for sex and years of disease progression.</div></div><div><h3>Results</h3><div>A total of 243 patients were included, 174 (71.6%) with Crohn's disease and 69 (28.4%) with ulcerative colitis; 73 (30.2%) reported fatigue. Patients with fatigue had a significantly lower quality of life EuroQol-5D-5L: 60.08 vs. 76.34, (<em>P</em> <!-->&lt;<!--> <!-->.001, 95%<!--> <span>C</span>I: 12.15-20.36) and IBDQ-9 57.53 vs. 76.54 (<em>P</em> <!-->&lt;<!--> <!-->.001, 95%<!--> <!-->CI: 15.35-22.67). The regression model adjusted for sex and years of disease included moderate disease activity (OR: 4.88, <em>P</em> <!-->&lt;<!--> <!-->.001, 95%<!--> <!-->CI: 2.13-11. 14), probable case of anxiety (OR: 2.16, <em>P</em> <!-->=<!--> <!-->.031, 95%<!--> <!-->CI: 0.78-4.34), probable case of depression (OR: 2.86, <em>P</em> <!-->=<!--> <!-->.004, 95%<!--> <!-->CI: 1.41-5.81).</div></div><div><h3>Conclusions</h3><div>Fatigue was significantly associated with poorer health-related quality of life in patients with moderate disease activity and those experiencing anxiety or depression. These findings highlight the necessity of a comprehensive approach that includes early detection of fatigue and associated psychosocial factors.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"49 2","pages":"Article 502557"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145029684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of early immunosuppression at ulcerative colitis onset in the biological era 生物时代溃疡性结肠炎发病早期免疫抑制的预测因素。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1016/j.gastrohep.2025.502533
Gisela Piñero , Edgar Castillo , Carlos González-Muñoza , Anna Calm , Clàudia Pujol , Jordi Gordillo , Margalida Calafat , Federico Bertoletti , Esther Garcia-Planella , Míriam Mañosa , Eugeni Domènech

Background

Unlike Crohn's disease, ulcerative colitis (UC) lacks predictive factors of a bad prognosis. Therefore, immunosuppressant therapy is only considered in a step-up strategy when steroid refractoriness or dependency develops.

Objective

To identify predictive factors for the early use of immunosuppressants, biological agents and colectomy in UC.

Patients and methods

Retrospective, observational study of an incident cohort of UC at two referral centres over a 7-year period. Demographic, clinical, endoscopic and biologic variables at UC diagnosis were collected and early use (within five years) of immunosuppressants, biological agents and colectomy was assessed for a maximum of five years.

Results

A total of 239 patients were included. At baseline, 32% presented with extensive colitis, 15% severe disease activity and 13% large ulcers at diagnostic endoscopy. At the end of follow-up, 24% were exposed to thiopurines, 18% to biologicals and 4% were colectomized. The need for thiopurines, biological agents or colectomy was independently associated with extensive UC at diagnosis (OR 5.3; IC95% 1.6–17.2), the need for corticosteroids at disease onset (OR 7.8; IC95% 2.6–23.9) and proximal progression during follow-up (OR 13; IC95% 2.3–73.4).

Conclusions

Less than a third of patients with UC use thiopurines or biological agents within the first five years of disease course. Unfortunately, there are no predictive factors robust enough to allow for the early introduction of advanced therapies at disease onset.
背景:与克罗恩病不同,溃疡性结肠炎(UC)缺乏不良预后的预测因素。因此,免疫抑制治疗只有在类固醇难治性或依赖性发展时才被认为是一种升级策略。目的:探讨UC患者早期应用免疫抑制剂、生物制剂及结肠切除术的预测因素。患者和方法:回顾性观察研究两个转诊中心7年期间的UC事件队列。收集UC诊断的人口学、临床、内镜和生物学变量,并评估免疫抑制剂、生物制剂和结肠切除术的早期使用(5年内),最长时间为5年。结果:共纳入239例患者。基线时,32%表现为广泛结肠炎,15%表现为严重疾病活动,13%表现为大溃疡。在随访结束时,24%暴露于硫嘌呤,18%暴露于生物制剂,4%被集体化。对硫嘌呤类药物、生物制剂或结肠切除术的需要与诊断时广泛的UC独立相关(or 5.3;IC95% 1.6-17.2),发病时对皮质类固醇的需求(OR 7.8;IC95% 2.6-23.9)和随访期间近端进展(OR 13;IC95% 2.3 - -73.4)。结论:不到三分之一的UC患者在疾病病程的前五年内使用硫嘌呤或生物制剂。不幸的是,没有足够强大的预测因素,可以在疾病发病时早期引入先进的治疗方法。
{"title":"Predictors of early immunosuppression at ulcerative colitis onset in the biological era","authors":"Gisela Piñero ,&nbsp;Edgar Castillo ,&nbsp;Carlos González-Muñoza ,&nbsp;Anna Calm ,&nbsp;Clàudia Pujol ,&nbsp;Jordi Gordillo ,&nbsp;Margalida Calafat ,&nbsp;Federico Bertoletti ,&nbsp;Esther Garcia-Planella ,&nbsp;Míriam Mañosa ,&nbsp;Eugeni Domènech","doi":"10.1016/j.gastrohep.2025.502533","DOIUrl":"10.1016/j.gastrohep.2025.502533","url":null,"abstract":"<div><h3>Background</h3><div>Unlike Crohn's disease, ulcerative colitis (UC) lacks predictive factors of a bad prognosis. Therefore, immunosuppressant therapy is only considered in a step-up strategy when steroid refractoriness or dependency develops.</div></div><div><h3>Objective</h3><div>To identify predictive factors for the early use of immunosuppressants, biological agents and colectomy in UC.</div></div><div><h3>Patients and methods</h3><div>Retrospective, observational study of an incident cohort of UC at two referral centres over a 7-year period. Demographic, clinical, endoscopic and biologic variables at UC diagnosis were collected and early use (within five years) of immunosuppressants, biological agents and colectomy was assessed for a maximum of five years.</div></div><div><h3>Results</h3><div>A total of 239 patients were included. At baseline, 32% presented with extensive colitis, 15% severe disease activity and 13% large ulcers at diagnostic endoscopy. At the end of follow-up, 24% were exposed to thiopurines, 18% to biologicals and 4% were colectomized. The need for thiopurines, biological agents or colectomy was independently associated with extensive UC at diagnosis (OR 5.3; IC95% 1.6–17.2), the need for corticosteroids at disease onset (OR 7.8; IC95% 2.6–23.9) and proximal progression during follow-up (OR 13; IC95% 2.3–73.4).</div></div><div><h3>Conclusions</h3><div>Less than a third of patients with UC use thiopurines or biological agents within the first five years of disease course. Unfortunately, there are no predictive factors robust enough to allow for the early introduction of advanced therapies at disease onset.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"49 2","pages":"Article 502533"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144667556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-based differences in the relationship between health-related quality of life, physical activity, and inflammatory markers in people with Crohn's disease 克罗恩病患者健康相关生活质量、身体活动和炎症标志物之间关系的性别差异
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1016/j.gastrohep.2025.502494
Susana Herrero-Rodríguez , Leticia Martín-Cordero , Raquel Mayordomo , Isabel Gálvez , Eduardo Ortega

Objective

Managing Crohn's disease (CD) requires addressing factors beyond medical treatment alone, including health-related quality of life (HRQoL) and physical activity. This study aimed to understand the relationships between different intensities of physical activity, HRQoL, and inflammatory biomarkers in CD, considering sex as a factor that could influence these associations.

Patients and methods

A cross-sectional, observational study was conducted in 63 CD patients. Sociodemographic and clinical data, including C-reactive protein and fecal calprotectin determinations, were collected. The Inflammatory Bowel Disease Questionnaire (IBDQ-9) and the Global Physical Activity Questionnaire (GPAQ) were used to measure HRQoL and physical activity, respectively.

Results

Although females had similar inflammation levels to males, they engaged in less physical activity and reported lower HRQoL (especially in psychosocial wellbeing). Sedentary behavior and intense physical activity negatively impacted HRQoL in the overall sample and only in females. Higher fecal calprotectin concentrations were associated with poorer HRQoL in the total group and only in males. No correlation was found between inflammation and physical activity.

Conclusions

Sex differences influence the relationship between inflammation, physical activity, and HRQoL in CD. Given the greater impact of CD on emotional and social wellbeing in females, irrespective of physiological measures of inflammation, our findings support considering sex differences, which may inform more individualized approaches to improve HRQoL.
目的:克罗恩病(CD)的管理需要解决药物治疗之外的因素,包括健康相关生活质量(HRQoL)和身体活动。本研究旨在了解不同强度的体力活动、HRQoL和CD中炎症生物标志物之间的关系,并考虑性别是可能影响这些关联的一个因素。患者和方法:对63例CD患者进行了横断面观察性研究。收集社会人口学和临床数据,包括c反应蛋白和粪便钙保护蛋白测定。采用炎症性肠病问卷(IBDQ-9)和全球身体活动问卷(GPAQ)分别测量HRQoL和身体活动。结果:尽管女性的炎症水平与男性相似,但她们从事的体力活动较少,HRQoL(尤其是心理健康方面)也较低。在整个样本中,久坐行为和高强度的身体活动对HRQoL产生负面影响,且仅在女性中。在整个组中,较高的粪便钙保护蛋白浓度与较差的HRQoL相关,且仅在男性中存在。没有发现炎症和身体活动之间的相关性。结论:性别差异影响CD患者炎症、身体活动和HRQoL之间的关系。考虑到CD对女性情绪和社会福祉的影响更大,无论炎症的生理指标如何,我们的研究结果支持考虑性别差异,这可能会为改善HRQoL提供更个性化的方法。
{"title":"Sex-based differences in the relationship between health-related quality of life, physical activity, and inflammatory markers in people with Crohn's disease","authors":"Susana Herrero-Rodríguez ,&nbsp;Leticia Martín-Cordero ,&nbsp;Raquel Mayordomo ,&nbsp;Isabel Gálvez ,&nbsp;Eduardo Ortega","doi":"10.1016/j.gastrohep.2025.502494","DOIUrl":"10.1016/j.gastrohep.2025.502494","url":null,"abstract":"<div><h3>Objective</h3><div>Managing Crohn's disease (CD) requires addressing factors beyond medical treatment alone, including health-related quality of life (HRQoL) and physical activity. This study aimed to understand the relationships between different intensities of physical activity, HRQoL, and inflammatory biomarkers in CD, considering sex as a factor that could influence these associations.</div></div><div><h3>Patients and methods</h3><div>A cross-sectional, observational study was conducted in 63 CD patients. Sociodemographic and clinical data, including C-reactive protein and fecal calprotectin determinations, were collected. The Inflammatory Bowel Disease Questionnaire (IBDQ-9) and the Global Physical Activity Questionnaire (GPAQ) were used to measure HRQoL and physical activity, respectively.</div></div><div><h3>Results</h3><div>Although females had similar inflammation levels to males, they engaged in less physical activity and reported lower HRQoL (especially in psychosocial wellbeing). Sedentary behavior and intense physical activity negatively impacted HRQoL in the overall sample and only in females. Higher fecal calprotectin concentrations were associated with poorer HRQoL in the total group and only in males. No correlation was found between inflammation and physical activity.</div></div><div><h3>Conclusions</h3><div>Sex differences influence the relationship between inflammation, physical activity, and HRQoL in CD. Given the greater impact of CD on emotional and social wellbeing in females, irrespective of physiological measures of inflammation, our findings support considering sex differences, which may inform more individualized approaches to improve HRQoL.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"49 2","pages":"Article 502494"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144198942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between sleep quality and disease activity in inflammatory bowel disease: A systematic review and meta-analysis. 炎症性肠病患者睡眠质量与疾病活动度的关系:一项系统综述和荟萃分析
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-30 DOI: 10.1016/j.gastrohep.2026.502699
Shizhan Chen, Chengmin Yu, Fei Fang, Qian Zhou, Dandan Chen

Objective: The purpose of this review was to examine evidence on the association between poor sleep quality and disease activity in inflammatory bowel disease (IBD).

Patients and methods: PubMed, Embase, Scopus, and the Web of Science were searched till July 15, 2025, for studies reporting an association between sleep quality and IBD. Outcomes were pooled as Odds ratio (OR) in a random-effects meta-analysis model.

Results: Twenty studies were included. Most studies were cross-sectional. The majority used the Pittsburgh Sleep Questionnaire Index for assessing sleep quality. Meta-analysis showed that poor sleep quality was significantly associated with active disease in IBD (OR: 2.54 95% CI: 1.85, 3.49 I2=80%). Subgroup analysis showed a significant association between poor sleep quality and active disease in CD, but not in UC. In subgroup analyses based on study design, results were significant only in cross-sectional studies, not in cohort studies. Meta-regression analysis using the moderators: sample size, age, males, body mass index, disease duration, prevalence of active disease and poor sleep quality, IBD surgery, and Newcastle Ottawa scale score did not show significant results.

Conclusions: Low-quality evidence, mostly from cross-sectional data, suggests an association between poor sleep quality and active disease in IBD. However, the findings were not replicated by prospective cohort studies. Given the predominance of cross-sectional data, the possibility of reverse causation, whereby active disease itself leads to impaired sleep quality, cannot be excluded. Further robust studies are needed to support these findings.

目的:本综述的目的是研究炎症性肠病(IBD)患者睡眠质量差与疾病活动之间的关系。患者和方法:检索PubMed, Embase, Scopus和Web of Science,直到2025年7月15日,报告睡眠质量和IBD之间关联的研究。在随机效应荟萃分析模型中,将结果汇总为优势比(OR)。结果:纳入20项研究。大多数研究是横断面的。大多数人使用匹兹堡睡眠问卷指数来评估睡眠质量。荟萃分析显示,睡眠质量差与IBD的活动性疾病显著相关(OR: 2.54 95% CI: 1.85, 3.49 I2=80%)。亚组分析显示,睡眠质量差与CD患者的活动性疾病之间存在显著关联,但与UC患者无关。在基于研究设计的亚组分析中,结果仅在横断面研究中显著,在队列研究中不显著。meta回归分析使用调节因子:样本量、年龄、男性、体重指数、疾病持续时间、活动性疾病患病率和睡眠质量差、IBD手术和纽卡斯尔渥太华量表评分没有显示显著结果。结论:低质量的证据,主要来自横断面数据,表明睡眠质量差与IBD活动性疾病之间存在关联。然而,这些发现并没有在前瞻性队列研究中得到证实。鉴于横断面数据的优势,不能排除反向因果关系的可能性,即活动性疾病本身导致睡眠质量受损。需要进一步的有力研究来支持这些发现。
{"title":"Association between sleep quality and disease activity in inflammatory bowel disease: A systematic review and meta-analysis.","authors":"Shizhan Chen, Chengmin Yu, Fei Fang, Qian Zhou, Dandan Chen","doi":"10.1016/j.gastrohep.2026.502699","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502699","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this review was to examine evidence on the association between poor sleep quality and disease activity in inflammatory bowel disease (IBD).</p><p><strong>Patients and methods: </strong>PubMed, Embase, Scopus, and the Web of Science were searched till July 15, 2025, for studies reporting an association between sleep quality and IBD. Outcomes were pooled as Odds ratio (OR) in a random-effects meta-analysis model.</p><p><strong>Results: </strong>Twenty studies were included. Most studies were cross-sectional. The majority used the Pittsburgh Sleep Questionnaire Index for assessing sleep quality. Meta-analysis showed that poor sleep quality was significantly associated with active disease in IBD (OR: 2.54 95% CI: 1.85, 3.49 I<sup>2</sup>=80%). Subgroup analysis showed a significant association between poor sleep quality and active disease in CD, but not in UC. In subgroup analyses based on study design, results were significant only in cross-sectional studies, not in cohort studies. Meta-regression analysis using the moderators: sample size, age, males, body mass index, disease duration, prevalence of active disease and poor sleep quality, IBD surgery, and Newcastle Ottawa scale score did not show significant results.</p><p><strong>Conclusions: </strong>Low-quality evidence, mostly from cross-sectional data, suggests an association between poor sleep quality and active disease in IBD. However, the findings were not replicated by prospective cohort studies. Given the predominance of cross-sectional data, the possibility of reverse causation, whereby active disease itself leads to impaired sleep quality, cannot be excluded. Further robust studies are needed to support these findings.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502699"},"PeriodicalIF":1.9,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Accuracy of Non-Invasive Fatty Liver Indexes and Their Association with ECORE-BF scale in a Cohort of 386,924 Spanish Workers. 386,924名西班牙工人非侵入性脂肪肝指标的诊断准确性及其与ECORE-BF量表的关系
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.gastrohep.2026.502656
Marta Marina Arroyo, Ignacio Ramírez Gallegos, Ángel Arturo López-González, Carla Busquets-Cortés, Joan Obrador de Hevia, Pedro Juan Tárraga López, José Ignacio Ramírez-Manent

Objective: To evaluate the diagnostic accuracy of five non-invasive fatty liver indices and their association with obesity in a large cohort of Spanish workers, stratified by sex.

Patients and methods: A cross-sectional analysis was conducted on 386,924 workers (232,814 men and 154,110 women) who underwent routine occupational health assessments between 2009 and 2019. Anthropometric, clinical, and biochemical parameters were collected following standardized procedures. Physical activity and adherence to the Mediterranean diet were assessed using validated IPAQ and PREDIMED questionnaires. Diagnostic performance was evaluated using ROC curves and area under the curve (AUC) values for each fatty liver index.

Results: All indices showed significant sex-based differences. FLI and LAP presented the highest AUC values for identifying obesity in both sexes (FLI: AUC 0.907 in men and 0.972 in women; LAP: AUC 0.836 in men and 0.878 in women). FLI also demonstrated the strongest association with higher obesity prevalence across tertiles. ZJU showed good performance, whereas HSI and FLD exhibited lower accuracy, particularly among men. Lifestyle factors and education level influenced index values, with sedentary behavior, low adherence to the Mediterranean diet, and lower educational attainment associated with worse index performance.

Conclusions: FLI and LAP are the most accurate non-invasive indices for identifying obesity-associated fatty liver in this large Spanish working population. Their performance varies by sex and is influenced by sociodemographic and lifestyle factors. These findings support the relevance of FLI and LAP for large-scale screening and highlight the importance of integrating lifestyle assessments into occupational health evaluations.

目的:评估五种非侵入性脂肪肝指数的诊断准确性及其与肥胖的关系,在西班牙工人的一大队列中,按性别分层。患者和方法:对2009年至2019年间接受常规职业健康评估的386,924名工人(232,814名男性和154,110名女性)进行了横断面分析。人体测量、临床和生化参数按照标准化程序收集。使用经验证的IPAQ和PREDIMED问卷对身体活动和对地中海饮食的依从性进行评估。采用ROC曲线和各脂肪肝指数的曲线下面积(AUC)值评估诊断效能。结果:各指标均存在显著的性别差异。在两性中,FLI和LAP识别肥胖的AUC值最高(男性FLI: AUC 0.907,女性0.972;男性LAP: AUC 0.836,女性0.878)。FLI还显示出与高肥胖患病率之间的最强关联。ZJU表现出良好的表现,而HSI和FLD表现出较低的准确性,特别是在男性中。生活方式因素和受教育程度影响指数值,久坐行为、地中海饮食依从性低、受教育程度低与较差的指数表现相关。结论:FLI和LAP是西班牙大量工作人群中识别肥胖相关脂肪肝最准确的非侵入性指标。他们的表现因性别而异,并受社会人口和生活方式因素的影响。这些发现支持FLI和LAP与大规模筛查的相关性,并强调了将生活方式评估纳入职业健康评估的重要性。
{"title":"Diagnostic Accuracy of Non-Invasive Fatty Liver Indexes and Their Association with ECORE-BF scale in a Cohort of 386,924 Spanish Workers.","authors":"Marta Marina Arroyo, Ignacio Ramírez Gallegos, Ángel Arturo López-González, Carla Busquets-Cortés, Joan Obrador de Hevia, Pedro Juan Tárraga López, José Ignacio Ramírez-Manent","doi":"10.1016/j.gastrohep.2026.502656","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502656","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the diagnostic accuracy of five non-invasive fatty liver indices and their association with obesity in a large cohort of Spanish workers, stratified by sex.</p><p><strong>Patients and methods: </strong>A cross-sectional analysis was conducted on 386,924 workers (232,814 men and 154,110 women) who underwent routine occupational health assessments between 2009 and 2019. Anthropometric, clinical, and biochemical parameters were collected following standardized procedures. Physical activity and adherence to the Mediterranean diet were assessed using validated IPAQ and PREDIMED questionnaires. Diagnostic performance was evaluated using ROC curves and area under the curve (AUC) values for each fatty liver index.</p><p><strong>Results: </strong>All indices showed significant sex-based differences. FLI and LAP presented the highest AUC values for identifying obesity in both sexes (FLI: AUC 0.907 in men and 0.972 in women; LAP: AUC 0.836 in men and 0.878 in women). FLI also demonstrated the strongest association with higher obesity prevalence across tertiles. ZJU showed good performance, whereas HSI and FLD exhibited lower accuracy, particularly among men. Lifestyle factors and education level influenced index values, with sedentary behavior, low adherence to the Mediterranean diet, and lower educational attainment associated with worse index performance.</p><p><strong>Conclusions: </strong>FLI and LAP are the most accurate non-invasive indices for identifying obesity-associated fatty liver in this large Spanish working population. Their performance varies by sex and is influenced by sociodemographic and lifestyle factors. These findings support the relevance of FLI and LAP for large-scale screening and highlight the importance of integrating lifestyle assessments into occupational health evaluations.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502656"},"PeriodicalIF":1.9,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the role of ammonia in MASLD: From a neurotoxin to a metabolic by-product. 解析氨在MASLD中的作用:从神经毒素到代谢副产物。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.gastrohep.2026.502664
Carola Zurita-Palomo, Franz Martín-Bermudo, Douglas Maya-Miles, Javier Ampuero, Manuel Romero-Gómez, Rocío Gallego-Durán
{"title":"Deciphering the role of ammonia in MASLD: From a neurotoxin to a metabolic by-product.","authors":"Carola Zurita-Palomo, Franz Martín-Bermudo, Douglas Maya-Miles, Javier Ampuero, Manuel Romero-Gómez, Rocío Gallego-Durán","doi":"10.1016/j.gastrohep.2026.502664","DOIUrl":"10.1016/j.gastrohep.2026.502664","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502664"},"PeriodicalIF":1.9,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SPLENIC LACERATION AS A COMPLICATION AFTER DIAGNOSTIC COLONOSCOPY. 脾撕裂是诊断性结肠镜检查后的并发症。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.gastrohep.2026.502657
M Calderón-Chamizo, J M Tapia-Cabo, J Ternero-Fonseca, A Naranjo-Pérez, A Pérez-Ramírez
{"title":"SPLENIC LACERATION AS A COMPLICATION AFTER DIAGNOSTIC COLONOSCOPY.","authors":"M Calderón-Chamizo, J M Tapia-Cabo, J Ternero-Fonseca, A Naranjo-Pérez, A Pérez-Ramírez","doi":"10.1016/j.gastrohep.2026.502657","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502657","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502657"},"PeriodicalIF":1.9,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling Hidden Malnutrition in IBD: A Cross-Sectional Multi-Tool Analysis Reveals High Prevalence Beyond Weight-Based Assessment. 揭示IBD中隐藏的营养不良:一项横断面多工具分析揭示了基于体重评估之外的高患病率。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.gastrohep.2026.502662
Mahrez Fissah, Salam Bennouar, Adel Rechach, Lydia Haddab, Chaima Hadj Sadok, Naila Zairit, Mehdi Rabhia, Samia Abdi, Ahcene Chibane

Objective:  Malnutrition is a serious complication of inflammatory bowel disease (IBD), associated with increased morbidity, postoperative complications, and reduced quality of life. While well-documented in Western populations, data on nutritional status in understudied IBD populations remain scarce. This study aims to comprehensively evaluate the nutritional status of an IBD cohort at a tertiary referral center in Algeria using multiple assessment tools, to identify factors associated with malnutrition, and to explore the relationship between inflammatory activity and nutritional parameters.

Patients and methods:  A prospective cross-sectional study was conducted at a tertiary referral center. Nutritional assessment included anthropometric measurements, biochemical parameters, and four validated scores: CONUT, McClave, HALP, and GLIM criteria. Disease activity was assessed using the Harvey-Bradshaw Index for Crohn's disease and the Partial Mayo Score for ulcerative colitis.

Results:  Ninety patients were included forming a Crohn's-dominant cohort (94.4% Crohn's disease). Mean age was 39.5 ± 13.7 years, 53.3% female. Overall, 24.4% had active disease. Nutritional assessment revealed: 18.9% had low BMI (<18.5 kg/m²). Malnutrition prevalence varied by tool: CONUT 46.7%, McClave 20.6%, HALP 26.8%, and GLIM 14.6%. Active disease significantly correlated with nutritional deterioration and worse nutritional scores (p<0.01). Multivariate logistic regression analysis was performed indicates that although clinical flare and hospitalization were associated with malnutrition in univariate analysis, none of the variables reached statistical significance in the multivariate analysis Conclusions: Malnutrition is highly prevalent in IBD patients, particularly during active disease. The inflammatory process plays a crucial role in nutritional deterioration. Systematic nutritional screening using composite scores should be integrated into routine management, especially during disease flares.

目的:营养不良是炎症性肠病(IBD)的严重并发症,与发病率增加、术后并发症和生活质量下降有关。虽然在西方人群中有充分的记录,但关于未充分研究的IBD人群营养状况的数据仍然很少。本研究旨在利用多种评估工具综合评估阿尔及利亚三级转诊中心IBD队列的营养状况,确定与营养不良相关的因素,并探讨炎症活动与营养参数之间的关系。患者和方法:一项前瞻性横断面研究在三级转诊中心进行。营养评估包括人体测量、生化参数和四个有效评分:CONUT、McClave、HALP和GLIM标准。使用克罗恩病的哈维-布拉德肖指数和溃疡性结肠炎的部分梅奥评分来评估疾病活动性。结果:90例患者被纳入克罗恩病优势队列(94.4%为克罗恩病)。平均年龄39.5±13.7岁,女性53.3%。总体而言,24.4%患有活动性疾病。营养评估显示:18.9%的人身体质量指数低(
{"title":"Unveiling Hidden Malnutrition in IBD: A Cross-Sectional Multi-Tool Analysis Reveals High Prevalence Beyond Weight-Based Assessment.","authors":"Mahrez Fissah, Salam Bennouar, Adel Rechach, Lydia Haddab, Chaima Hadj Sadok, Naila Zairit, Mehdi Rabhia, Samia Abdi, Ahcene Chibane","doi":"10.1016/j.gastrohep.2026.502662","DOIUrl":"https://doi.org/10.1016/j.gastrohep.2026.502662","url":null,"abstract":"<p><strong>Objective: </strong> Malnutrition is a serious complication of inflammatory bowel disease (IBD), associated with increased morbidity, postoperative complications, and reduced quality of life. While well-documented in Western populations, data on nutritional status in understudied IBD populations remain scarce. This study aims to comprehensively evaluate the nutritional status of an IBD cohort at a tertiary referral center in Algeria using multiple assessment tools, to identify factors associated with malnutrition, and to explore the relationship between inflammatory activity and nutritional parameters.</p><p><strong>Patients and methods: </strong> A prospective cross-sectional study was conducted at a tertiary referral center. Nutritional assessment included anthropometric measurements, biochemical parameters, and four validated scores: CONUT, McClave, HALP, and GLIM criteria. Disease activity was assessed using the Harvey-Bradshaw Index for Crohn's disease and the Partial Mayo Score for ulcerative colitis.</p><p><strong>Results: </strong> Ninety patients were included forming a Crohn's-dominant cohort (94.4% Crohn's disease). Mean age was 39.5 ± 13.7 years, 53.3% female. Overall, 24.4% had active disease. Nutritional assessment revealed: 18.9% had low BMI (<18.5 kg/m²). Malnutrition prevalence varied by tool: CONUT 46.7%, McClave 20.6%, HALP 26.8%, and GLIM 14.6%. Active disease significantly correlated with nutritional deterioration and worse nutritional scores (p<0.01). Multivariate logistic regression analysis was performed indicates that although clinical flare and hospitalization were associated with malnutrition in univariate analysis, none of the variables reached statistical significance in the multivariate analysis Conclusions: Malnutrition is highly prevalent in IBD patients, particularly during active disease. The inflammatory process plays a crucial role in nutritional deterioration. Systematic nutritional screening using composite scores should be integrated into routine management, especially during disease flares.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502662"},"PeriodicalIF":1.9,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterologia y hepatologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1